ZA201502654B - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome - Google Patents
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeInfo
- Publication number
- ZA201502654B ZA201502654B ZA2015/02654A ZA201502654A ZA201502654B ZA 201502654 B ZA201502654 B ZA 201502654B ZA 2015/02654 A ZA2015/02654 A ZA 2015/02654A ZA 201502654 A ZA201502654 A ZA 201502654A ZA 201502654 B ZA201502654 B ZA 201502654B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyrazolopyridazines
- methods
- hearing loss
- degenerative diseases
- loss associated
- Prior art date
Links
- NMEPLWZDUIIAAC-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]pyridazine Chemical class C1=NN=C2C=NNC2=C1 NMEPLWZDUIIAAC-UHFFFAOYSA-N 0.000 title 1
- 206010011878 Deafness Diseases 0.000 title 1
- 208000014769 Usher Syndromes Diseases 0.000 title 1
- 230000010370 hearing loss Effects 0.000 title 1
- 231100000888 hearing loss Toxicity 0.000 title 1
- 208000016354 hearing loss disease Diseases 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261718593P | 2012-10-25 | 2012-10-25 | |
| US201361775376P | 2013-03-08 | 2013-03-08 | |
| PCT/US2013/066938 WO2014066835A1 (en) | 2012-10-25 | 2013-10-25 | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201502654B true ZA201502654B (en) | 2016-07-27 |
Family
ID=50545355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2015/02654A ZA201502654B (en) | 2012-10-25 | 2015-04-20 | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2912038B1 (enExample) |
| JP (1) | JP6290910B2 (enExample) |
| AU (1) | AU2013334138B2 (enExample) |
| CA (1) | CA2889537C (enExample) |
| ES (1) | ES2693166T3 (enExample) |
| IL (1) | IL238287B (enExample) |
| PL (1) | PL2912038T3 (enExample) |
| TR (1) | TR201816028T4 (enExample) |
| WO (1) | WO2014066835A1 (enExample) |
| ZA (1) | ZA201502654B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5902293B2 (ja) | 2011-04-25 | 2016-04-13 | アッシャー・サード・イニシアティブ・インコーポレイテッド | ピラゾロピリダジンおよび網膜変性疾患およびアッシャー症候群に伴う聴覚損失を治療するための方法 |
| US9227976B2 (en) | 2012-10-25 | 2016-01-05 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| CA2889494C (en) * | 2012-10-25 | 2018-12-18 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| EP4178580B1 (en) | 2020-07-09 | 2025-11-05 | Usher III Initiative, Inc. | Bf 844 for use in the treatment of cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2295550A3 (en) * | 2001-04-30 | 2011-12-14 | Vertex Pharmaceuticals Incorporated | Crystal structures of GSK-3beta protein and protein complexes and their use |
| ATE554087T1 (de) * | 2004-10-29 | 2012-05-15 | Abbott Lab | Neue kinaseinhibitoren |
| AR052559A1 (es) * | 2005-01-21 | 2007-03-21 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir cdk's y gsk's |
| WO2009062118A2 (en) * | 2007-11-07 | 2009-05-14 | Foldrx Pharmaceuticals, Inc. | Modulation of protein trafficking |
| AU2009262068C1 (en) * | 2008-06-27 | 2015-07-02 | Celgene Car Llc | Heteroaryl compounds and uses thereof |
| JP5902293B2 (ja) * | 2011-04-25 | 2016-04-13 | アッシャー・サード・イニシアティブ・インコーポレイテッド | ピラゾロピリダジンおよび網膜変性疾患およびアッシャー症候群に伴う聴覚損失を治療するための方法 |
| CA2889494C (en) * | 2012-10-25 | 2018-12-18 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
-
2013
- 2013-10-25 JP JP2015539867A patent/JP6290910B2/ja active Active
- 2013-10-25 ES ES13849803.5T patent/ES2693166T3/es active Active
- 2013-10-25 CA CA2889537A patent/CA2889537C/en active Active
- 2013-10-25 AU AU2013334138A patent/AU2013334138B2/en active Active
- 2013-10-25 TR TR2018/16028T patent/TR201816028T4/tr unknown
- 2013-10-25 WO PCT/US2013/066938 patent/WO2014066835A1/en not_active Ceased
- 2013-10-25 EP EP13849803.5A patent/EP2912038B1/en active Active
- 2013-10-25 PL PL13849803T patent/PL2912038T3/pl unknown
-
2015
- 2015-04-14 IL IL238287A patent/IL238287B/en active IP Right Grant
- 2015-04-20 ZA ZA2015/02654A patent/ZA201502654B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL238287B (en) | 2018-07-31 |
| AU2013334138A1 (en) | 2015-05-07 |
| CA2889537C (en) | 2017-12-12 |
| HK1214263A1 (en) | 2016-07-22 |
| JP2015535256A (ja) | 2015-12-10 |
| PL2912038T3 (pl) | 2019-02-28 |
| EP2912038A1 (en) | 2015-09-02 |
| AU2013334138B2 (en) | 2017-07-27 |
| JP6290910B2 (ja) | 2018-03-07 |
| TR201816028T4 (tr) | 2018-11-21 |
| EP2912038B1 (en) | 2018-08-15 |
| ES2693166T3 (es) | 2018-12-07 |
| CA2889537A1 (en) | 2014-05-01 |
| WO2014066835A1 (en) | 2014-05-01 |
| EP2912038A4 (en) | 2016-04-20 |
| IL238287A0 (en) | 2015-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201502655B (en) | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome | |
| GB2500915B (en) | Arrangement and method | |
| ZA201507790B (en) | Enhanced adoptive cell therapy | |
| ZA201504401B (en) | Filter arrangements; components; assemblies; and, methods | |
| SG10201609812SA (en) | System and process for retina phototherapy | |
| TWI561481B (en) | Glass manufacturing apparatus and methods | |
| EP2856994A4 (en) | ABSORBENT ARTICLE AND MANUFACTURING METHOD THEREFOR | |
| DK3292875T3 (en) | Compositions and methods for treating diseases | |
| SG11201601294PA (en) | Method for producing retinal tissue and retina-related cells | |
| ZA201307961B (en) | Pyrazolopyridazines and methods for treating retinal-degenarative diseases and hearing loss associated with usher syndrome | |
| SG11201501838RA (en) | Completion assembly and methods for use thereof | |
| GB201216649D0 (en) | Agents and methods | |
| EP2907494A4 (en) | TABLE FOR WHEELCHAIR AND WHEELCHAIR COMPRISING THE SAME | |
| EP2934412A4 (en) | LAMINATE AND METHOD FOR THE MANUFACTURE THEREOF | |
| GB201310158D0 (en) | Medico-surgical assemblies and means | |
| GB201217070D0 (en) | Airflow modification patch and method | |
| GB201213782D0 (en) | Process and dressing | |
| IL238287A0 (en) | Pyrazolopyridazines and methods for the treatment of diseases of retinal degeneration and hearing loss associated with Asher syndrome | |
| GB2504303B (en) | Earphones and earplugs | |
| SG11201500047QA (en) | Vacuum forming process and use | |
| EP2809285A4 (en) | HYPERBARE CHAMBER SYSTEM AND ASSOCIATED METHODS | |
| GB201221092D0 (en) | Assemblies and methods | |
| GB201213778D0 (en) | Process and dressng | |
| GB201222736D0 (en) | Composition and process | |
| GB2519994B (en) | Assemblies and methods |